World’s biggest-selling drug company cheats competitors and consumers as they extend their exclusive right to sell Humira
The makers of the world’s biggest-selling drug cheat competitors and consumers as they extend their exclusive right to sell Humira. Humira is a rheumatoid-arthritis and gut-disorders drug that enjoys sales of around $18 billion a year. Last Tuesday, one of its patents was set to expire. When a drug’s patent expires, generic manufacturers are free …